About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5614 record(s)
Req # A-2024-000012
Adverse Drug Reactions (ADRs). Report numbers: 001067949, 001069982.Organization: Health Canada
April 2024
Req # A-2024-000017
Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.Organization: Health Canada
April 2024
Req # A-2024-000028
Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.Organization: Health Canada
April 2024
Req # A-2024-000032
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.Organization: Health Canada
April 2024
Req # A-2024-000068
Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.Organization: Health Canada
April 2024
Req # 52100-20-001-2024
Any and all documents, correspondence, including emails and recordings or any radio and telephone communications relating to the occupancy and availability of and any requests for anchorage at the English Bay and Vancouver innder Harbour anchorages, and/or any other anchorages managed, operated or allocated by the VFPA Oct 19, 2021 to October 22, 2021Organization: Vancouver Fraser Port Authority
April 2024
Req # 52100-20-004-2024
1.Any records (including telephone records, any correspondence between the VFPA and any other party, and any subsequent investigation reports regarding the reservation of an anchorage for the M/V Zim Kingston for the period of October 15, 2021, to October 22, 2021, including (without limitation) any such records generated or relied upon by VFPA in respect of the appearance of VFPA representatives before the House of Commons Standing Committee on Fisheries and Oceans in March 2022, concerning the subject of marine cargo container spills; 2.Any records regarding vessel anchorage reservations and availability in west coast anchorages for the period of October 15, 2021, to October 22, 2021; and 3. Any records (including, without limitation, any correspondence between the VFPA and the Canadian Coast Guard, or the U.S. Coast Guard, or any other party) regarding the availability of certain sheltered waters in Juan de Fuca Strait (including, without limitation, those waters known as the “Racetrack”) to accommodate vessels awaiting an anchorage on the west coast of British Columbia, between October 19, 2021, and October 22, 2021.Organization: Vancouver Fraser Port Authority
April 2024
Req # 52100-20-007-2024
A record of all of the Ships/Vessels that have accessed the Ioco Terminal over the past 12 months, along with the following additional information; each of the ships sizes (DWT), amount of product being transported, and the final destinations of each shipment.Organization: Vancouver Fraser Port Authority
April 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.Organization: Health Canada
March 2024